Mycophenolate Mofetil

CAS 128794-94-5 19 current records 8 historicalSmall Molecule

Who holds supplier records for Mycophenolate Mofetil? 19 organisations hold a current record for Mycophenolate Mofetil: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 12 of them hold a valid EU Certificate of Suitability (13 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (8), China (3), Slovenia (1), Taiwan (1) and 2 other countries (2); not recorded for 4.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Mycophenolate Mofetil: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/mycophenolate-mofetil

Reading the evidence

  • 19 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 12 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Mycophenolate Mofetil expires 16 Aug 2039. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (19)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Mycophenolate Mofetil. Country is the organisation's recorded country, not necessarily the manufacturing site.

India8China3Slovenia1Taiwan1Netherlands1Czech Republic1Country not recorded for 4
  • CONCORD BIOTECH LTD
    Active DMF 19231, 29553 · latest filing Sept 2015
    IndiaCEP Company GMP cert on record
  • CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD
    Active DMF 33333, 18494 · latest filing Dec 2018
    Company GMP cert on record
  • Biocon Limited
    Active DMF 16406 · latest filing Jan 2003
    IndiaCEP
  • Chongqing Daxin Pharmaceutical Co., Ltd.
    Active DMF 20758, 36449 · latest filing Dec 2021
    ChinaCEP
  • Emcure Pharmaceuticals Limited
    Active DMF 25744 · latest filing Feb 2012
    IndiaCEP Company GMP cert on record
  • HISUN PHARMACEUTICAL HANGZHOU CO LTD
    Active DMF 26405 · latest filing Nov 2012
    CEP
  • Lek Pharmaceuticals D.D.
    Active DMF 25323, 18936 · latest filing Sept 2011
    SloveniaCEP Company GMP cert on record
  • RAKSHIT PHARMACEUTICALS LTD
    Active DMF 42257 · latest filing Aug 2025
    CEP
  • SOLARA ACTIVE PHARMA SCIENCES LTD
    Active DMF 33021 · latest filing Jul 2018
    IndiaCEP Company GMP cert on record
  • Wuxi Fortune Pharmaceutical Co., Ltd.
    Active DMF 22786, 33934 · latest filing Aug 2019
    ChinaCEP Company GMP cert on record
  • DASAMI LAB PRIVATE LTD
    Active DMF 42682 · latest filing Nov 2025
    India Company GMP cert on record
  • Formosa Laboratories, Inc.
    Active DMF 22046 · latest filing Oct 2008
    Taiwan Company GMP cert on record
  • Intas Pharmaceuticals Ltd.
    Active DMF 43405 · latest filing Feb 2026
    India Company GMP cert on record
  • JOYANG LABORATORIES
    Active DMF 40978 · latest filing Oct 2025
    China
  • Shandong New Time Pharmaceutical Co Ltd
    Active DMF 20655 · latest filing Jul 2007
    Company GMP cert on record
  • TAPI NL BV
    Active DMF 20072 · latest filing Dec 2006
    Netherlands
  • Apotex Pharmachem India Pvt. Ltd.
    Inactive DMF 25746, 21227 · latest filing Jan 2012
    IndiaCEP
  • Rpg Life Sciences Ltd.
    Inactive DMF 26578 · latest filing Jan 2013
    IndiaCEP Company GMP cert on record
  • TAPI Czech Industries s.r.o
    Czech RepublicCEP Company GMP cert on record
Need Mycophenolate Mofetil sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (13)

Certificates of Suitability on the EDQM register for Mycophenolate Mofetil, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 21 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
TAPI CZECH INDUSTRIES S.R.O. OpavaCZ
CEP 2005-239 - Rev 07
Mycophenolate mofetil
May 2026Inspected Oct 2024
Czechia
EMCURE PHARMACEUTICALS LIMITED PuneIN
CEP 2019-089 - Rev 03
Mycophenolate mofetil
Mar 2026—
RPG LIFE SCIENCES LIMITED Navi MumbaiIN
CEP 2025-548 - Rev 00
Mycophenolate mofetil, Process II
Feb 2026—
WUXI FORTUNE PHARMACEUTICAL CO., LTD. WuxiCN
CEP 2019-159 - Rev 01
Mycophenolate mofetil, Process 2
Nov 2024Inspected Mar 2025
Germany
BIOCON LIMITED BengaluruIN
CEP 2010-162 - Rev 09
Mycophenolate mofetil, Process II
Nov 2024—
LEK PHARMACEUTICALS D.D. LjubljanaSI
CEP 2011-317 - Rev 06
Mycophenolate mofetil, Process B
Sept 2024Inspected Nov 2025
Slovenia
RAKSHIT PHARMACEUTICALS LIMITED VishakhapatnamIN
CEP 2022-182 - Rev 00
Mycophenolate mofetil
May 2024—
CONCORD BIOTECH LIMITED AhmedabadIN
CEP 2009-361 - Rev 06
Mycophenolate mofetil
Mar 2024—
SOLARA ACTIVE PHARMA SCIENCES LIMITED ChennaiIN
CEP 2019-344 - Rev 01
Mycophenolate mofetil
Jan 2024—
CHONGQING DAXIN PHARMACEUTICAL CO., LTD. Shuitu TownCN
R0-CEP 2020-104 - Rev 00
Mycophenolate mofetil
Mar 2022—
HISUN PHARMACEUTICAL (HANGZHOU) CO., LTD. Hangzhou CityCN
R1-CEP 2012-308 - Rev 02
Mycophenolate mofetil
Oct 2021—
APOTEX PHARMACHEM INDIA PVT. LTD BangaloreIN
R1-CEP 2013-263 - Rev 00
Mycophenolate mofetil, MYM
Feb 2019—
BIOCON LIMITED BangaloreIN
R1-CEP 2007-052 - Rev 00
Mycophenolate mofetil
Jul 2013—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (8)

Organisations whose Type II DMFs for Mycophenolate Mofetil are no longer active. These show a past filing, not current supply.

Show all 8 historical records
  • China · Inactive DMF 25336 · filed Sept 2011
  • South · Inactive DMF 24981 · filed May 2011
  • HAUDONG MEDICINE CO LTD
    Inactive DMF 22977 · filed Jul 2009
  • SHANGHAI YOUNGGREEN BIOTECH CO LTD
    Inactive DMF 21423 · filed Mar 2008
  • DSM ANTI INFECTIVES BV
    Inactive DMF 21232 · filed Jan 2008
  • India · Inactive DMF 20679 · filed Nov 2007
  • Germany · Inactive DMF 20948 · filed Oct 2007
  • IVAX PHARMACEUTICALS SRO
    Inactive DMF 18989 · filed Nov 2005

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (38 listed products contain Mycophenolate Mofetil). The latest listed patent expires 16 Aug 2039. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Mycophenolate mofetil is an immunosuppressive agent used to prevent organ transplant rejection. It acts by inhibiting the proliferation of activated T and B lymphocytes.

Chemical identity

IUPAC name
2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-2-benzofuran-5-yl)-4-methylhex-4-enoate
Canonical SMILES
CC1=C2COC(=O)C2=C(C(=C1OC)C/C=C(\C)/CCC(=O)OCCN3CCOCC3)O
InChIKey
RTGDFNSFWBGLEC-SYZQJQIISA-N
Synonyms
CellCept API, myclausen, mycophenolate mofetil teva, mycophenylate mofetil, myfenax, myhibbin, nsc-724229, nsc-758905, rs-61443

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Antimetabolite Immunosuppressant

Therapeutic areas

ImmunosuppressionTransplantation

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Mycophenolate Mofetil?

19 organisations hold an active US FDA Type II Drug Master File or a CEP for Mycophenolate Mofetil: CONCORD BIOTECH LTD (India), CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD, Biocon Limited (India), Chongqing Daxin Pharmaceutical Co., Ltd. (China), Emcure Pharmaceuticals Limited (India), HISUN PHARMACEUTICAL HANGZHOU CO LTD, Lek Pharmaceuticals D.D. (Slovenia) and RAKSHIT PHARMACEUTICALS LTD, and 11 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Mycophenolate Mofetil Drug Master Files are active?

CONCORD BIOTECH LTD (DMF 19231, 29553), CHUNGHWA CHEMICAL SYNTHESIS AND BIOTECH CO LTD (DMF 33333, 18494), Biocon Limited (DMF 16406), Chongqing Daxin Pharmaceutical Co., Ltd. (DMF 20758, 36449), Emcure Pharmaceuticals Limited (DMF 25744), HISUN PHARMACEUTICAL HANGZHOU CO LTD (DMF 26405), Lek Pharmaceuticals D.D. (DMF 25323, 18936) and RAKSHIT PHARMACEUTICALS LTD (DMF 42257) and 8 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Mycophenolate Mofetil records mean?

8 organisations have only inactive Type II DMFs for Mycophenolate Mofetil. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Mycophenolate Mofetil have a European Certificate of Suitability?

Yes. 12 organisations hold a valid CEP for Mycophenolate Mofetil on the EDQM register, including TAPI CZECH INDUSTRIES S.R.O. Opava (CZ), EMCURE PHARMACEUTICALS LIMITED Pune (IN), RPG LIFE SCIENCES LIMITED Navi Mumbai (IN), WUXI FORTUNE PHARMACEUTICAL CO., LTD. Wuxi (CN), BIOCON LIMITED Bengaluru (IN) and LEK PHARMACEUTICALS D.D. Ljubljana (SI) and 7 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Mycophenolate Mofetil?

Yes. The latest patent listed for an approved US product containing Mycophenolate Mofetil expires 16 Aug 2039, across 38 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Mycophenolate Mofetil supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Mycophenolate Mofetil?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.